Metronomic Four-Drug Regimen Has Anti-tumor Activity in Pediatric Low-Grade Glioma; The Results of a Phase II Clinical Trial
about
Metronomic Four-Drug Regimen Has Anti-tumor Activity in Pediatric Low-Grade Glioma; The Results of a Phase II Clinical Trial
description
im Januar 2018 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована у 2018
@uk
name
Metronomic Four-Drug Regimen H ...... s of a Phase II Clinical Trial
@en
Metronomic Four-Drug Regimen H ...... s of a Phase II Clinical Trial
@nl
type
label
Metronomic Four-Drug Regimen H ...... s of a Phase II Clinical Trial
@en
Metronomic Four-Drug Regimen H ...... s of a Phase II Clinical Trial
@nl
prefLabel
Metronomic Four-Drug Regimen H ...... s of a Phase II Clinical Trial
@en
Metronomic Four-Drug Regimen H ...... s of a Phase II Clinical Trial
@nl
P2093
P2860
P356
P1476
Metronomic Four-Drug Regimen H ...... s of a Phase II Clinical Trial
@en
P2093
Arnauld Verschuur
Elisabeth Jouve
Isabelle Aerts
Jean-Claude Gentet
Marie-Amélie Heng-Maillard
Nadège Corradini
Natasha Entz-Werle
Nicolas André
Nicolas Sirvent
Pascal Chastagner
P2860
P356
10.3389/FPHAR.2018.00950
P407
P577
2018-01-01T00:00:00Z